How many investments has RV Invest GmbH made?

RV Invest GmbH has 10 tracked investments.

What stage does RV Invest GmbH invest at?

RV Invest GmbH invests at the Seed, Series A stages.

What sectors does RV Invest GmbH focus on?

RV Invest GmbH focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is RV Invest GmbH located?

RV Invest GmbH is headquartered in Ravensburg, DE.

Who does RV Invest GmbH co-invest with?

RV Invest GmbH most often shares deals with Frazier Life Sciences, Andreessen Horowitz, GV (Google Ventures), among 44 tracked co-investors.

RV Invest GmbH

Venture capital

Ravensburg · Seed–Series A · 8 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into RV Invest GmbH

Paths you didn't know you had: your email and LinkedIn already hold routes to the RV Invest GmbH team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

RV Invest is a venture capital fund dedicated to backing innovations that improve patients' lives. The firm invests early and works closely with founders and researchers to bring outstanding scientific ideas to market. Its focus is on highly differentiated technical solutions in biotechnology and medicine that have the potential to become future standards of care. The portfolio spans areas such as cell and gene therapy, RNA-guided technologies, radiopharmaceuticals, epigenetic medicine, rare disease treatments, and cancer immunotherapy, reflecting a strong orientation toward cutting-edge therapeutic platforms addressing high unmet medical needs.

Invests inBiotech Digital Health Healthtech Medical Devices Europe Germany United Kingdom United States

Source: firm website, verified Oct 2, 2026.

Leave your own feedback

Stage

Seed–Series A

Ravensburg, DE

Instruments

Equity

Tracked investments

Team · 8 people

from the firm's website

Aleksei Zeifman· Investment Director

Holds a PhD in computational chemistry and an MBA from Mannheim Business School, with over 10 years in biotech as a drug development startup co-founder and investor. Previously invested in biotech and medtech at RBV Capital and the CVC arm of reinsurer SCOR.

Alexey A. Lugovskoy· Investment Committee

President and CEO of Diagonal Therapeutics and Entrepreneur-in-Residence at Atlas Ventures. Previously held senior roles at Dragonfly, Morphic, Merrimack, and Biogen; holds a PhD in biophysics from Harvard.

Carla Benichou· Senior Investment Analyst

Graduated in business administration from ESADE and holds an MSc in applied neurosciences from King's College London. Has four years of experience with startups through roles at Gartner, biotech accelerator BaseLaunch, and impact VC fund LBS.

Lu Zheng· Investment Associate

Holds a PhD in neuroscience from EPFL and an MBA from St. Gallen University, with industry experience at Nestlé Research Center and Syneos Health Consulting. Previously gained VC experience at +ND Capital and Ysios Capital.

Nicholas H. Vetter· Investment Committee

Holds an MBA from SDA Bocconi and studied human physiology at the University of Colorado. CEO of OncoBeta, a radiation oncology company, serves on healthcare boards, and is part of the third generation of ownership of Vetter Pharma.

Patrick Lally· Investment Committee

Partner at Petrichor with over 15 years of healthcare investing experience overseeing origination, diligence, and asset management. Previously invested at OrbiMed Advisors and Fortress Investment Group; holds an MBA from Wharton and an AB from Princeton.

Susanne Schaffert· Investment Committee

Former President of Novartis Oncology with 25 years in pharmaceuticals specializing in oncology, having led a broad portfolio including CAR-T and radioligand therapies. Holds a PhD in chemistry from the University of Erlangen and serves on multiple biotech boards.

Timo Köhler· VP Finance

Holds a Diploma in Business Administration from DHBW Mannheim, a Bachelor from Open University London, and an MBA from WWU Muenster. Gained finance management experience at international companies including Merck and Vetter Pharma.

What they invest in

from 9 of 10 portfolio companies

Biotech ×9Healthtech ×7Medical Devices ×5AI & Machine Learning ×4Deep Tech ×3Longevity ×3Digital Health ×1

HQs:United States×5Germany×1Sweden×1

Who they back

founder profiles across 6 portfolio companies

55%

repeat founders

of 11 founders with career history

Where their founders studiedfrom 10 founders with education data

Imperial College London ×2Universidade do Porto ×2

What their founders studiedfrom 10 founders with field-of-study data

Life Sciences ×6Engineering ×3

Where their founders worked beforefrom 11 founders with career history

CNC UC ×2Lund University ×2

Investments · 10 tracked

founders shown can be your intro path

Akribion Therapeuticsakribion-therapeutics.com

Akribion Therapeutics develops an RNA-guided, nuclease enzyme-based technology for programmable cell depletion using its G-dase E payload.

BiotechDeep TechLongevity

Alestaalestatherapeutics.com in

Alesta Therapeutics develops therapies for rare diseases, with research focused on genetic diseases and oncology.

BiotechHealthtech

Ilan Ganot(CEO)inBenit Maru(CMO)Matthias Van Woensel(CSO)in

Co-investorsDroia Ventures Frazier Life Sciences Novartis Venture Fund Frazier Healthcare Partners MPM BioImpact RTW Investments L.P.+1 more

Arda Therapeuticsardatx.com in 𝕏

Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases.

AI & Machine LearningBiotechDigital HealthLongevityMedical DevicesAustin, US

Adam Freund(Founder & Chief Executive Officer)in Remi-Martin Laberge(Founder and Chief Technology Officer)in

Board Vineeta Agarwala(Director)in

Co-investorsage1 Alumni Ventures Andreessen Horowitz Gaingels GV (Google Ventures)Lifelink +7 more

Asgard Therapeuticsasgardthx.com in 𝕏

Asgard Therapeutics develops direct cell reprogramming technologies that convert cancer cells into dendritic cells to restore anti-cancer immune responses.

AI & Machine LearningBiotechHealthtechMedical DevicesLund, SE

Cristiana Pires(Co-founder and CEO)in Fábio Rosa(Co-founder and VP of Research)in Filipe Pereira(Co-founder and Head of Innovation)in

Co-investorsIndustrifonden LU Innovation Novo Holdings Boehringer Ingelheim Venture Fund

Diagonal Therapeuticsdiagonaltx.com in

Diagonal Therapeutics develops multi-specific clustering antibody therapeutics that bind multiple cell-surface receptors to activate or inhibit dysregulated signaling pathways underlying chronic diseases.

AI & Machine LearningBiotechHealthtechWatertown, US

Alex Lugovskoy(Founder and Chief Executive Officer)inMichael Gladstone(Founder)

Co-investorsAtlas Venture EcoR1 Capital Frazier Life Sciences RA Capital Sanofi Ventures Viking Global

Immusoftimmusoft.com

Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.

BiotechDeep TechHealthtechSeattle, US

Matthew Scholz(Founder)in Sean Ainsworth(Chief Executive Officer)inRobert Sikorski(Chief Medical Officer)Rob Hayes(Chief Scientific Officer)inScott McIvor(Chief Development Officer)Eric Garcia(Executive Officer)in

Co-investorsBioRock Ventures Boston Harbor Angels Breakout Ventures EQx Fund Invariantes Fund Michigan Capital Network +6 more

ITMitm-radiopharma.com in

ITM is a vertically integrated biotechnology company specializing in precision oncology through radioisotope production and radiopharmaceutical development, with clinical programs advanced through subsidiary Lumara Bio.

BiotechHealthtechMedical Devices

Alexander Pironi(Executive Vice President, Global Head of Radioisotopes)inDr. Konstantin Zhernosekov(Chief Scientific Officer & Managing Director ITM Medical Isotopes & ITM Oncologics)

Co-investorsCapmont Nextech Invest

Tune Therapeuticstunetx.com in 𝕏Mar 2023

Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications.

BiotechDeep TechHealthtechLongevityMedical DevicesDurham and Seattle, US

Akira Matsuno(Co-Founder, President, CFO, COO)in Derek Jantz(Executive Officer)in Charles Gersbach(Co-Founder)in John McHutchison(CEO, Chairman of the Board)in Dan McHugh(Co-Founder, Investor)in Blythe Sather(Executive Officer)in

Co-investorsDuke Capital Partners Hatteras Venture Partners Mission Biocapital New Enterprise Associates (NEA)Pappas Capital Saisei Ventures +2 more

Valink Therapeuticsvalinktx.com inSeed

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Arne Scheu(Founder)in Irsyad Khairil(Founder)in

Co-investorsHoxton Ventures LongeVC Metaplanet Oxonian Ventures P53 Invest SynBioVen +9 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ITM Isotope Technologies Munich SE

Portfolio news

latest coverage across their companies

Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine - Immusoft

Immusoft · immusoft.com · Mar 30, 2026

Valink Therapeutics Closes $11.8M Pre-A Financing Round

Valink Therapeutics · finsmes.com · Oct 20, 2025

ITM Radiopharma– ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds

ITM · itm-radiopharma.com · May 27, 2025

Frequently asked questions

How many investments has RV Invest GmbH made?: RV Invest GmbH has 10 tracked investments.
What stage does RV Invest GmbH invest at?: RV Invest GmbH invests at the Seed, Series A stages.
What sectors does RV Invest GmbH focus on?: RV Invest GmbH focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is RV Invest GmbH located?: RV Invest GmbH is headquartered in Ravensburg, DE.
Who does RV Invest GmbH co-invest with?: RV Invest GmbH most often shares deals with Frazier Life Sciences, Andreessen Horowitz, GV (Google Ventures), among 44 tracked co-investors.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

Canaan Partners

Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.

$500K – $20M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M